Sec. 606. Communication plans
91 words·~1 min read·
/bill/115/hr/2430/eh/section-606A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 505–1(e)(3) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355–1(e)(3) ) is amended— in subparagraph (B), by striking ; or ; in subparagraph (C), by striking the period and inserting ; or ; and by adding at the end the following: disseminating information to health care providers about drug formulations or properties, including information about the limitations or patient care implications of such formulations or properties, and how such formulations or properties may be related to serious adverse drug events associated with use of the drug. .
Connections1 off-index
1 reference not yet in our index
- 21 USC 355–1(e)(3)
Citation graph
cites case law
Sec. 606
Communication plans
Cite21 USC 355–1(e)(3)
Cites 1Cited by 0 across 0 sources